ACE and diabetes mellitus: “Repurposing the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent and/or treat gastrointestinal complications associated with Diabetes mellitus”, International Patent Application No. PCT/IB2025/052714, filed by Universidade do Porto and REQUIMTE—Rede de Química e Tecnologia, priority filing PT 119319 (Portugal), 14 March 2024.